04 February 2022
KOL Investor Event on Iron Deficiency
Shield Therapeutics announces it will host a Key Opinion Leader (“KOL”) event for Investors on “Iron Deficiency Treatment Innovation” with a focus on clinical utility of Accrufer®/Feraccru® on Thursday 10 February 2022 at 10am (EST) / 3pm (GMT).
For more details click here.